Bold statement: a single setback in spring training could reshape a team’s entire season. Joe Ryan’s MRI morning not only questions the Twins’ rotation depth but also touches on broader questions about health, timing, and the firepower Minnesota can bring to the 2026 campaign. But here’s where it gets controversial: even a minor back issue in early camp can snowball into bigger problems once the season starts.
The Minnesota Twins announced that ace Joe Ryan was a late scratch from his scheduled Grapefruit League start against the Red Sox. He is dealing with tightness in the lower back on his right side and has begun an MRI to assess the injury’s scope. Until tests are complete, the exact severity remains unknown. It’s entirely possible this is routine early-camp soreness as Ryan ramps up his throwing program, but the timing raises eyebrows given the team’s recent health realities.
The stakes feel higher because Pablo López’s 2026 season is effectively wiped out by Tommy John surgery. Losing López would have weakened Minnesota’s rotation even before any further health concerns surfaced. If Ryan is sidelined for an extended period, the Twins’ hopes of maintaining a competitive trajectory could be in jeopardy from the outset.
Beyond club concerns, Ryan is slated to anchor the United States’ World Baseball Classic roster. A minor back issue might lead the Twins to pull him for precautionary reasons, especially if he’s behind in spring innings. The team may prefer to protect him for the WBC and ensure he’s ready for a full workload when the season starts, rather than risk a longer shutdown.
On the field, Ryan just completed the first All-Star-caliber season of his career. He posted a 3.42 ERA, a 28.2% strikeout rate, and a 5.7% walk rate across 171 innings. He’s known for attacking hitters with power-heavy contact and has faced homers at times, but his performance over the past four seasons (3.78 ERA, 5.7% walk rate, 27.5% K rate over 614 2/3 innings) positions him as a front-line starter. His durability has been solid for a pitcher his age, aside from a teres major strain that ended his 2024 season in August.
Trade chatter hasn’t stopped around Ryan, though the Twins opted to hold him during last summer’s big selloff. With arbitration control through 2027, he remains an affordable asset for a team watching payroll and talent development carefully. If Minnesota again finds itself out of contention by this year’s trade deadline, expect rumors about Ryan to heat up again—contingent, of course, on his health and performance.
In short, Ryan’s health news arrives at a delicate moment for Minnesota: a strong rotation, a possible WBC impact, and the ongoing question of whether the Twins can sustain competitive momentum through a win-now window without overextending their young ace. How the team manages his return, whether he contributes in the WBC, and what this means for trade dynamics could shape Minnesota’s season in surprising ways. Do you think the Twins should prioritize protecting Ryan in spring, or push to maximize innings now and deal with potential consequences later? Share your take in the comments.
